| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | CXCR chemokine receptor binding | 2.42e-05 | 18 | 195 | 4 | GO:0045236 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | A1BG A2M PF4 PF4V1 ADAM11 ERBIN USH2A COL4A1 LAMB4 COL11A1 VWF ADAMTS4 LAMA3 PAPLN LOXL2 LTBP1 | 4.79e-05 | 530 | 198 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 1.64e-04 | 122 | 198 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | extracellular matrix | A1BG A2M PF4 PF4V1 ADAM11 ERBIN USH2A COL4A1 LAMB4 COL11A1 VWF ADAMTS4 LAMA3 PAPLN LOXL2 LTBP1 ADAMTS14 | 1.78e-04 | 656 | 198 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | A1BG A2M PF4 PF4V1 ADAM11 ERBIN USH2A COL4A1 LAMB4 COL11A1 VWF ADAMTS4 LAMA3 PAPLN LOXL2 LTBP1 ADAMTS14 | 1.84e-04 | 658 | 198 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | platelet alpha granule | 2.58e-04 | 93 | 198 | 6 | GO:0031091 | |
| GeneOntologyCellularComponent | platelet alpha granule lumen | 4.35e-04 | 67 | 198 | 5 | GO:0031093 | |
| Domain | ZnF_C2HC | 1.22e-06 | 55 | 187 | 7 | SM00343 | |
| Domain | Znf_CCHC | 1.22e-06 | 55 | 187 | 7 | IPR001878 | |
| Domain | Laminin_G_2 | 2.69e-06 | 40 | 187 | 6 | PF02210 | |
| Domain | LamG | 4.78e-06 | 44 | 187 | 6 | SM00282 | |
| Domain | Chemokine_CXC_CS | 6.48e-06 | 13 | 187 | 4 | IPR018048 | |
| Domain | CXC_Chemokine_domain | 9.01e-06 | 14 | 187 | 4 | IPR033899 | |
| Domain | Chemokine_CXC | 1.61e-05 | 16 | 187 | 4 | IPR001089 | |
| Domain | SMALL_CYTOKINES_CXC | 2.09e-05 | 17 | 187 | 4 | PS00471 | |
| Domain | Laminin_G | 2.44e-05 | 58 | 187 | 6 | IPR001791 | |
| Domain | LAM_G_DOMAIN | 3.66e-05 | 38 | 187 | 5 | PS50025 | |
| Domain | - | 4.74e-05 | 95 | 187 | 7 | 2.60.120.200 | |
| Domain | PF4 | 9.97e-05 | 2 | 187 | 2 | IPR027222 | |
| Domain | TSP_1 | 4.19e-04 | 63 | 187 | 5 | PF00090 | |
| Domain | TSP1 | 4.84e-04 | 65 | 187 | 5 | SM00209 | |
| Domain | TSP1_rpt | 4.84e-04 | 65 | 187 | 5 | IPR000884 | |
| Domain | TSP1 | 4.84e-04 | 65 | 187 | 5 | PS50092 | |
| Domain | Cadherin_2 | 4.84e-04 | 65 | 187 | 5 | PF08266 | |
| Domain | Cadherin_N | 4.84e-04 | 65 | 187 | 5 | IPR013164 | |
| Domain | Laminin_N | 5.02e-04 | 16 | 187 | 3 | IPR008211 | |
| Domain | LamNT | 5.02e-04 | 16 | 187 | 3 | SM00136 | |
| Domain | LAMININ_NTER | 5.02e-04 | 16 | 187 | 3 | PS51117 | |
| Domain | Laminin_N | 5.02e-04 | 16 | 187 | 3 | PF00055 | |
| Domain | SPHK1-interactor_AKAP_110 | 5.90e-04 | 4 | 187 | 2 | IPR008382 | |
| Domain | AKAP_110 | 5.90e-04 | 4 | 187 | 2 | PF05716 | |
| Domain | Cadherin_CS | 8.02e-04 | 109 | 187 | 6 | IPR020894 | |
| Domain | SCY | 8.09e-04 | 42 | 187 | 4 | SM00199 | |
| Domain | Chemokine_IL8-like_dom | 9.66e-04 | 44 | 187 | 4 | IPR001811 | |
| Domain | IL8 | 9.66e-04 | 44 | 187 | 4 | PF00048 | |
| Domain | CADHERIN_1 | 9.68e-04 | 113 | 187 | 6 | PS00232 | |
| Domain | Cadherin | 9.68e-04 | 113 | 187 | 6 | PF00028 | |
| Domain | Groucho_enhance | 9.78e-04 | 5 | 187 | 2 | IPR009146 | |
| Domain | TLE_N | 9.78e-04 | 5 | 187 | 2 | PF03920 | |
| Domain | Groucho/TLE_N | 9.78e-04 | 5 | 187 | 2 | IPR005617 | |
| Domain | CADHERIN_2 | 1.01e-03 | 114 | 187 | 6 | PS50268 | |
| Domain | - | 1.01e-03 | 114 | 187 | 6 | 2.60.40.60 | |
| Domain | CA | 1.06e-03 | 115 | 187 | 6 | SM00112 | |
| Domain | EGF_1 | 1.10e-03 | 255 | 187 | 9 | PS00022 | |
| Domain | Cadherin-like | 1.11e-03 | 116 | 187 | 6 | IPR015919 | |
| Domain | Cadherin | 1.21e-03 | 118 | 187 | 6 | IPR002126 | |
| Domain | Ank_2 | 1.49e-03 | 215 | 187 | 8 | PF12796 | |
| Domain | ADAM_spacer1 | 1.51e-03 | 23 | 187 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.51e-03 | 23 | 187 | 3 | PF05986 | |
| Domain | ConA-like_dom | 1.67e-03 | 219 | 187 | 8 | IPR013320 | |
| Domain | Peptidase_M12B_ADAM-TS | 1.71e-03 | 24 | 187 | 3 | IPR013273 | |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A1 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 7.82e-21 | 25 | 209 | 12 | 17684299 | |
| Pubmed | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 5.28e-17 | 23 | 209 | 10 | 18602769 | |
| Pubmed | DAB2IP ZFYVE16 TSPOAP1 ERBIN STARD9 PCDH19 DOP1B SYNE1 HEATR5A CEP192 EPG5 PHF3 TLE4 PPIP5K1 LIMCH1 PDZD2 | 4.16e-09 | 407 | 209 | 16 | 12693553 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 DENND4A MAST2 ERBIN POLR1F PTPN14 STARD9 PLEKHA5 WNK3 DOP1B MIIP JCAD PARD3B CEP192 CBL C2CD3 PHF3 PLEKHA3 ANKRD11 AKAP11 LIMCH1 PHLDB2 | 1.41e-08 | 861 | 209 | 22 | 36931259 |
| Pubmed | Placental PPARγ regulates spatiotemporally diverse genes and a unique metabolic network. | FAM90A14 FAM90A17 FAM90A19 FAM90A1 FAM90A22 FAM90A23 FAM90A7 FAM90A9 FAM90A8 FAM90A10 | 6.50e-08 | 164 | 209 | 10 | 22967998 |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | BCL9L DENND4A CFAP251 ISLR MAST2 FAT1 RBM19 PLEKHA5 USP36 ZFHX4 PHF3 ZMYM4 PHLDB2 | 3.36e-07 | 361 | 209 | 13 | 26167880 |
| Pubmed | DAB2IP ERBIN ZNF518A PLCB1 PLEKHA5 DOP1B AKAP6 SYNE1 PHF3 AKAP11 | 1.21e-06 | 225 | 209 | 10 | 12168954 | |
| Pubmed | 1.21e-06 | 14 | 209 | 4 | 32060285 | ||
| Pubmed | Cloning and genomic localization of the murine LPS-induced CXC chemokine (LIX) gene, Scyb5. | 2.84e-06 | 17 | 209 | 4 | 12439624 | |
| Pubmed | 2.92e-06 | 102 | 209 | 7 | 11214970 | ||
| Pubmed | 3.63e-06 | 18 | 209 | 4 | 19584075 | ||
| Pubmed | Improving GENCODE reference gene annotation using a high-stringency proteogenomics workflow. | 4.22e-06 | 6 | 209 | 3 | 27250503 | |
| Pubmed | LncGata6 maintains stemness of intestinal stem cells and promotes intestinal tumorigenesis. | 4.22e-06 | 6 | 209 | 3 | 30224759 | |
| Pubmed | 7.00e-06 | 21 | 209 | 4 | 16079250 | ||
| Pubmed | 7.36e-06 | 7 | 209 | 3 | 27918915 | ||
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 9.47e-06 | 170 | 209 | 8 | 23314748 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | TET2 BCL9L BPTF MKI67 NCOA2 ZNF521 NCOR2 ZFHX4 TLE4 ZMYM4 RAI1 | 1.02e-05 | 351 | 209 | 11 | 38297188 |
| Pubmed | DAB2IP ERBIN PTPN14 PCDH19 PLCB1 PLEKHA5 FAM135A SLC6A15 PARD3B CBL LRBA PHLDB2 | 1.05e-05 | 421 | 209 | 12 | 36976175 | |
| Pubmed | Anchoring and scaffold proteins for kinases and phosphatases. | 1.75e-05 | 9 | 209 | 3 | 9238861 | |
| Pubmed | Replication of a genome-wide case-control study of esophageal squamous cell carcinoma. | 2.00e-05 | 27 | 209 | 4 | 18649358 | |
| Pubmed | TET2 SEMA5B MRC2 PLCB1 PLEKHA5 AKAP6 USP36 IBTK SLIT3 CNTNAP2 AKAP11 ZMYM4 RAI1 | 2.14e-05 | 529 | 209 | 13 | 14621295 | |
| Pubmed | 2.30e-05 | 94 | 209 | 6 | 32062451 | ||
| Pubmed | 2.49e-05 | 10 | 209 | 3 | 11807172 | ||
| Pubmed | Evolutionary history and genome organization of DUF1220 protein domains. | 2.49e-05 | 10 | 209 | 3 | 22973535 | |
| Pubmed | ERBIN BPTF FASN PTPN14 PLEKHA5 NCOA2 FLNA NUMA1 NSD1 CBL PHF3 LRBA ZMYM4 | 3.15e-05 | 549 | 209 | 13 | 38280479 | |
| Pubmed | 3.51e-05 | 31 | 209 | 4 | 31712428 | ||
| Pubmed | Platelet factor 4 mediates vascular smooth muscle cell injury responses. | 3.59e-05 | 2 | 209 | 2 | 23568488 | |
| Pubmed | Curcumin downregulates the inflammatory cytokines CXCL1 and -2 in breast cancer cells via NFkappaB. | 3.59e-05 | 2 | 209 | 2 | 17999991 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 20959601 | ||
| Pubmed | Expression of CXCL4 in microglia in vitro and in vivo and its possible signaling through CXCR3. | 3.59e-05 | 2 | 209 | 2 | 18248618 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 23245326 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 30917957 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 32538218 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 31200001 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 27223426 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 22615136 | ||
| Pubmed | Platelet factor 4 increases bone marrow B cell development and differentiation. | 3.59e-05 | 2 | 209 | 2 | 28914425 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 36930735 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 20525356 | ||
| Pubmed | Evidence for a granule targeting sequence within platelet factor 4. | 3.59e-05 | 2 | 209 | 2 | 15964840 | |
| Pubmed | CXCL4 is a novel nickel-binding protein and augments nickel allergy. | 3.59e-05 | 2 | 209 | 2 | 28319310 | |
| Pubmed | FcRn augments induction of tissue factor activity by IgG-containing immune complexes. | 3.59e-05 | 2 | 209 | 2 | 32187355 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 10319581 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 16961586 | ||
| Pubmed | Platelet factor 4 induces bone loss by inhibiting the integrin α5-FAK-ERK pathway. | 3.59e-05 | 2 | 209 | 2 | 37565509 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 23967336 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 2970963 | ||
| Pubmed | Non-equivalence of Wnt and R-spondin ligands during Lgr5+ intestinal stem-cell self-renewal. | 3.59e-05 | 2 | 209 | 2 | 28467820 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 33571109 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 26252654 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 14764524 | ||
| Pubmed | Platelet factor 4 is a biomarker for lymphatic-promoted disorders. | 3.59e-05 | 2 | 209 | 2 | 32525843 | |
| Pubmed | Intramedullary megakaryocytes internalize released platelet factor 4 and store it in alpha granules. | 3.59e-05 | 2 | 209 | 2 | 26256688 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 20961394 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 30259595 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 37058471 | ||
| Pubmed | Functionally independent AU-rich sequence motifs regulate KC (CXCL1) mRNA. | 3.59e-05 | 2 | 209 | 2 | 15994316 | |
| Pubmed | CXCL4 contributes to host defense against acute Pseudomonas aeruginosa lung infection. | 3.59e-05 | 2 | 209 | 2 | 30296305 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 20008299 | ||
| Pubmed | Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia. | 3.59e-05 | 2 | 209 | 2 | 26518435 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 22792197 | ||
| Pubmed | LOXL2 promotes aggrecan and gender-specific anabolic differences to TMJ cartilage. | 3.59e-05 | 2 | 209 | 2 | 33214607 | |
| Pubmed | Functional divergence between 2 chemokines is conferred by single amino acid change. | 3.59e-05 | 2 | 209 | 2 | 20688960 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 26345899 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 7700633 | ||
| Pubmed | Fc-modified HIT-like monoclonal antibody as a novel treatment for sepsis. | 3.59e-05 | 2 | 209 | 2 | 31722003 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 25440775 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 21111666 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 36329090 | ||
| Pubmed | Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia. | 3.59e-05 | 2 | 209 | 2 | 20724543 | |
| Pubmed | Heparin enhances uptake of platelet factor 4/heparin complexes by monocytes and macrophages. | 3.59e-05 | 2 | 209 | 2 | 25960020 | |
| Pubmed | Structural and functional comparison of the genes for human platelet factor 4 and PF4alt. | 3.59e-05 | 2 | 209 | 2 | 1695112 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 17848616 | ||
| Pubmed | Mapping early fate determination in Lgr5+ crypt stem cells using a novel Ki67-RFP allele. | 3.59e-05 | 2 | 209 | 2 | 25092767 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 29903575 | ||
| Pubmed | CXCL4 drives fibrosis by promoting several key cellular and molecular processes. | 3.59e-05 | 2 | 209 | 2 | 34986347 | |
| Pubmed | A CXCL1 paracrine network links cancer chemoresistance and metastasis. | 3.59e-05 | 2 | 209 | 2 | 22770218 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 18000617 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 17495129 | ||
| Pubmed | Platelet Factor 4 Attenuates Experimental Acute Liver Injury in Mice. | 3.59e-05 | 2 | 209 | 2 | 30971954 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 2890161 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 38547695 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 27183218 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 22706078 | ||
| Pubmed | Mutations of the TET2 and CBL genes: novel molecular markers in myeloid malignancies. | 3.59e-05 | 2 | 209 | 2 | 20195608 | |
| Pubmed | Chemokine PF4 Inhibits EV71 and CA16 Infections at the Entry Stage. | 3.59e-05 | 2 | 209 | 2 | 35579435 | |
| Pubmed | Platelet-associated PF-4 as a biomarker of early tumor growth. | 3.59e-05 | 2 | 209 | 2 | 17914028 | |
| Pubmed | Impact of CXCL1 overexpression on growth and invasion of prostate cancer cell. | 3.59e-05 | 2 | 209 | 2 | 23334998 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 11588041 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 38029855 | ||
| Pubmed | Dynamic intercellular redistribution of HIT antigen modulates heparin-induced thrombocytopenia. | 3.59e-05 | 2 | 209 | 2 | 29914979 | |
| Pubmed | Critical role of CXCL4 in the lung pathogenesis of influenza (H1N1) respiratory infection. | 3.59e-05 | 2 | 209 | 2 | 28120850 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 25403012 | ||
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 15613031 | ||
| Pubmed | Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection. | 3.59e-05 | 2 | 209 | 2 | 24463452 | |
| Pubmed | Cloning and sequence of a secretory protein induced by growth factors in mouse fibroblasts. | 3.59e-05 | 2 | 209 | 2 | 2909392 | |
| Pubmed | 3.59e-05 | 2 | 209 | 2 | 21738479 | ||
| Pubmed | Platelet factor 4 mediates inflammation in experimental cerebral malaria. | 3.59e-05 | 2 | 209 | 2 | 18692777 | |
| Pubmed | Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer. | 3.59e-05 | 2 | 209 | 2 | 25802102 | |
| Pubmed | Cep295 is a conserved scaffold protein required for generation of a bona fide mother centriole. | 3.59e-05 | 2 | 209 | 2 | 27562453 | |
| Cytoband | 8p23.1 | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.52e-10 | 154 | 209 | 11 | 8p23.1 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr8p23 | FAM90A14 FAM90A17 FAM90A19 FAM90A22 FAM90A23 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10 | 1.25e-08 | 234 | 209 | 11 | chr8p23 |
| Cytoband | 4q12-q21 | 2.06e-05 | 2 | 209 | 2 | 4q12-q21 | |
| Cytoband | Xp11.22 | 1.10e-04 | 54 | 209 | 4 | Xp11.22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp11 | 3.62e-04 | 377 | 209 | 8 | chrXp11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q13 | 7.94e-04 | 157 | 209 | 5 | chr4q13 | |
| GeneFamily | Neuroblastoma breakpoint family | 2.29e-05 | 23 | 134 | 4 | 662 | |
| GeneFamily | Ankyrin repeat domain containing | 4.49e-04 | 242 | 134 | 8 | 403 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 8.13e-04 | 25 | 134 | 3 | 504 | |
| GeneFamily | Zinc fingers MYND-type|A-kinase anchoring proteins | 1.26e-03 | 29 | 134 | 3 | 396 | |
| Coexpression | NABA_MATRISOME | A2M PF4 PF4V1 SEMA3G ADAM11 SEMA5B USH2A SERPINA7 COL4A1 LAMB4 COL11A1 VWF ADAMTS4 LAMA3 PAPLN CXCL1 CXCL2 LOXL2 SLIT3 WIF1 LTBP1 ADAMTS14 BMP15 | 2.85e-06 | 1026 | 196 | 23 | M5889 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 3.84e-06 | 162 | 196 | 9 | M45037 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.18e-05 | 40 | 196 | 5 | M5887 | |
| Coexpression | GSE17580_TREG_VS_TEFF_DN | 2.09e-05 | 200 | 196 | 9 | M3671 | |
| Coexpression | NABA_MATRISOME | A2M PF4 PF4V1 SEMA3G ADAM11 SEMA5B SERPINA7 COL4A1 COL11A1 VWF ADAMTS4 LAMA3 PAPLN CXCL1 CXCL2 LOXL2 SLIT3 WIF1 LTBP1 ADAMTS14 BMP15 | 2.36e-05 | 1008 | 196 | 21 | MM17056 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | NCKAP5 PRKD3 RGMA FASN FAT1 MRC2 MKI67 COL11A1 PARD3B HEATR5A LTBP1 LIMCH1 PHYHIPL | 2.89e-05 | 439 | 196 | 13 | M39054 |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 3.31e-05 | 212 | 196 | 9 | M39221 | |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP | ELOA2 ZFYVE16 DENND5A MIIP COL4A1 COL11A1 LAMA3 SLC6A15 CXCL1 CXCL2 NCOR2 NLRP14 PCDH9 | 3.90e-05 | 452 | 196 | 13 | M18685 |
| Coexpression | SMID_BREAST_CANCER_BASAL_UP | EXTL1 AGBL5 PRKD3 FAT1 PTPN14 GLDC MKI67 KLK5 FLNA PELI1 SLC6A15 LGR5 CXCL1 WIF1 KLK8 LTBP1 | 4.14e-05 | 662 | 196 | 16 | M8124 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | NCKAP5 RGMA FAT1 SEMA5B MRC2 AKAP6 COL11A1 PARD3B HEATR5A CXCL2 TLE2 LTBP1 LIMCH1 RASSF4 PHYHIPL | 4.95e-05 | 600 | 196 | 15 | M39055 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000 | RYR3 PCDH19 PLEKHA5 FAM135A NSD1 LAMA3 PCDHA11 PELI1 LGR5 IBTK C2CD3 ZFHX4 PHF3 TLE4 WIF1 RNF38 PRKG1 TNKS2 ZMYM4 PDZD2 | 3.86e-05 | 806 | 190 | 20 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_1000 | TET2 AHI1 ZFYVE16 PF4 ASB5 MRC2 PCDH19 PLCB1 PLEKHA5 GRIN3A FAM135A ANO1 PELI1 GRIA4 C2CD3 NEIL3 LTBP1 ZNF324B TNKS2 PCDH9 | 4.06e-05 | 809 | 190 | 20 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | AHI1 AGBL5 RYR3 RGL1 PLEKHA5 GRIN3A NCOA2 PCDHA11 PELI1 THSD7B IBTK C2CD3 ZFHX4 PHF3 KLK8 RNF38 LTBP1 PRKG1 TNKS2 ZMYM4 | 4.74e-05 | 818 | 190 | 20 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | TET2 CEP57L1 ZFP57 ISLR ARMCX4 MRC2 MKI67 WNK3 COL4A1 FLNA ANO1 ZNF521 GRIA4 CEP192 THSD7B LOXL2 PRKG1 PCDH9 PDZD2 | 7.38e-05 | 777 | 190 | 19 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | MIS18BP1 CEP57L1 ZFP57 TNFRSF18 ARMCX4 MAST2 ERBIN GJE1 GRK3 PCDH19 MKI67 PLEKHA5 NCOA2 NUMA1 DHX57 CEP164 RNF38 NEIL3 ZMYM4 | 7.76e-05 | 780 | 190 | 19 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#2_top-relative-expression-ranked_1000 | TET2 ZFYVE16 PF4 ASB5 PLCB1 ANO1 GRIA4 NEIL3 LTBP1 ZNF324B PCDH9 | 1.00e-04 | 305 | 190 | 11 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_1000_k2 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | DAB2IP MIS18BP1 ISLR RGL1 STARD9 PCDH19 COL11A1 ANO1 MSANTD2 PELI1 PARD3B CBL LOXL2 WIF1 ANKRD11 NEIL3 CEP295 PRKG1 PCDH9 | 1.10e-04 | 801 | 190 | 19 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | AHI1 RGL1 PLEKHA5 GRIN3A FAM135A NCOA2 PELI1 C2CD3 PHF3 RNF38 TNKS2 | 1.22e-04 | 312 | 190 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | PLEKHA5 FAM135A NSD1 PELI1 LGR5 IBTK C2CD3 PHF3 RNF38 PRKG1 TNKS2 ZMYM4 | 1.29e-04 | 369 | 190 | 12 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | AHI1 RYR3 PLCB1 PLEKHA5 GRIN3A FAM135A AKAP6 NSD1 PCDHA11 PELI1 SLC6A15 THSD7B IBTK ZFHX4 PHF3 WIF1 RNF38 PRKG1 TNKS2 | 1.44e-04 | 818 | 190 | 19 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_top-relative-expression-ranked_1000 | DBH RYR3 GRK3 PLCB1 GRIN3A FAM135A AKAP6 COL11A1 ZNF521 PCDHA11 SLC6A15 THSD7B CXCL1 CXCL2 CEP164 ZFHX4 WIF1 LIMCH1 PHYHIPL | 1.66e-04 | 827 | 190 | 19 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | AHI1 RGL1 PLEKHA5 NCOA2 PELI1 IBTK C2CD3 PHF3 RNF38 PRKG1 TNKS2 ZMYM4 | 1.91e-04 | 385 | 190 | 12 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | AHI1 RYR3 FANCD2 PLCB1 PLEKHA5 GRIN3A FAM135A NCOA2 SYNE1 ANO1 GRIA4 IBTK C2CD3 ZFHX4 NEIL3 LTBP1 TNKS2 PCDH9 | 2.07e-04 | 772 | 190 | 18 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | TET2 BCL9L TSPOAP1 PF4 TNFRSF18 AXIN2 RGMA FAT1 SEMA5B MRC2 PCDH19 TOLLIP FLNA COL11A1 VWF PCDHB8 ZNF521 GRIA4 CBL NCOR2 CORO1A TLE2 TLE4 NEIL3 | 2.08e-04 | 1208 | 190 | 24 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | AHI1 PLEKHA5 NSD1 PELI1 CEP164 IBTK C2CD3 ANKRD11 NEIL3 LIMCH1 TNKS2 | 2.51e-04 | 339 | 190 | 11 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | AHI1 NBPF12 ZFYVE16 TSPOAP1 ADAM11 AXIN2 RGMA RGL1 TSC22D1 ATXN7 MRC2 DENND5A COL11A1 RNPC3 NUMA1 PCDHB8 ZNF521 NBPF11 NBPF1 ZFHX4 ANKRA2 LOXL2 TLE4 POLI PPIP5K1 LTBP1 RAI1 | 2.78e-04 | 1466 | 190 | 27 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_100 | 2.82e-04 | 100 | 190 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | DENND4A PF4 PRKD3 TSC22D1 STARD9 PLCB1 GRIN3A SYNE1 CORO1A ZFHX4 SLIT3 WIF1 LIMCH1 LRBA TMEM63A | 2.82e-04 | 589 | 190 | 15 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | TET2 DENND4A NCKAP5 AGBL5 FAT1 SEMA5B GLDC STARD9 PCDH19 COL11A1 ANO1 C2CD3 TLE4 CNTNAP2 PPIP5K1 PHYHIPL PCDH9 | 3.26e-04 | 732 | 190 | 17 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_500 | TET2 AHI1 PF4 MRC2 PLEKHA5 FAM135A ANO1 PELI1 GRIA4 C2CD3 TNKS2 PCDH9 | 3.54e-04 | 412 | 190 | 12 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | RGL1 STARD9 PCDH19 COL11A1 ANO1 PELI1 CBL WIF1 ANKRD11 CEP295 PRKG1 PCDH9 | 3.62e-04 | 413 | 190 | 12 | gudmap_developingGonad_e14.5_ epididymis_500 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | DENND4A ZFP57 ISLR AXIN2 WNK3 FLNA ANO1 ZNF521 THSD7B LGR5 ZFHX4 LOXL2 AKAP11 LTBP1 PCDH9 PDZD2 CDK6 | 3.69e-04 | 740 | 190 | 17 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.85e-04 | 69 | 190 | 5 | gudmap_dev gonad_e11.5_M_GonMes_Sma_k2_1000 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | AHI1 PF4V1 TNFRSF18 FASN MRC2 COL4A1 SYNE1 SLIT3 KIAA1755 LTBP1 LIMCH1 | 1.71e-09 | 199 | 199 | 11 | 8b86c69aaf60feff53aa782559cfece7342a23de |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | A2M MRC2 STARD9 COL4A1 COL11A1 SYNE1 ZNF521 LTBP1 PRKG1 PCDH9 PHLDB2 | 1.80e-09 | 200 | 199 | 11 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | NCKAP5 PTPN14 COL4A1 VWF LAMA3 PARD3B LIMCH1 PRKG1 PHLDB2 PDZD2 | 5.25e-09 | 170 | 199 | 10 | e2023d66e70983c87dacbd6181d3426488d1fc57 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-08 | 195 | 199 | 10 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-08 | 195 | 199 | 10 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-Myoepithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.15e-08 | 197 | 199 | 10 | f0475ad9c09c6da418dba17d3d3c1aaa2ef9ab4e | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_epineurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | A2M SEMA3G MRC2 COL11A1 PCDHA11 PAPLN THSD7B SLIT3 LTBP1 ADAMTS14 | 2.36e-08 | 199 | 199 | 10 | fbec5c034576cb1adaf05f6f97cc5525d19e0c1b |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.09e-08 | 162 | 199 | 9 | 68c40d12689cc1b6c797e6e48173f0110f8144e4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.09e-08 | 162 | 199 | 9 | 735fa3f77b31a4189e431d05c326403c18cbbffb | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 1.38e-07 | 182 | 199 | 9 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.52e-07 | 184 | 199 | 9 | 327ff3ac8d2fecdd5d242bdc34f0dfdb1c59a68b | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.74e-07 | 187 | 199 | 9 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.82e-07 | 188 | 199 | 9 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.90e-07 | 189 | 199 | 9 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-07 | 191 | 199 | 9 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.17e-07 | 192 | 199 | 9 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.27e-07 | 193 | 199 | 9 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.48e-07 | 195 | 199 | 9 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-07 | 197 | 199 | 9 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.70e-07 | 197 | 199 | 9 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-07 | 197 | 199 | 9 | 452be45f4aac8459dd860493171f5f715368d663 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 2.70e-07 | 197 | 199 | 9 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-07 | 197 | 199 | 9 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-07 | 198 | 199 | 9 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-07 | 198 | 199 | 9 | b7e900fc0a1b3fa5e47dcc36ce6b0c3ce6bf9739 | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-07 | 199 | 199 | 9 | 78a9b26215874a46a910a4b93a51fcac1a597618 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 3.07e-07 | 200 | 199 | 9 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-07 | 200 | 199 | 9 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.07e-07 | 200 | 199 | 9 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-07 | 200 | 199 | 9 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.07e-07 | 200 | 199 | 9 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.07e-07 | 200 | 199 | 9 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.07e-07 | 200 | 199 | 9 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.70e-07 | 164 | 199 | 8 | b6df1e67a5ce5f2d86f4e1420f4ee931f760bf4d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-06 | 172 | 199 | 8 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 1.10e-06 | 172 | 199 | 8 | c62cad0f4212d1e9ea1ec3143ad3c4e06aff0ebf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-06 | 172 | 199 | 8 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-06 | 174 | 199 | 8 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-06 | 175 | 199 | 8 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.26e-06 | 175 | 199 | 8 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 | |
| ToppCell | Entopeduncular-Endothelial-MURAL-M1(Rgs5Acta2)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.31e-06 | 176 | 199 | 8 | 10c1f31c27e54b70f58f0b0086ac74dee2ce4197 | |
| ToppCell | Entopeduncular-Endothelial-MURAL|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.31e-06 | 176 | 199 | 8 | b8e52bec78876562a25f0b0de502aa9372b28bd2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-06 | 178 | 199 | 8 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.45e-06 | 124 | 199 | 7 | 36dfc702a570e1a1a6dde09f38badf9023ea7287 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 1.49e-06 | 179 | 199 | 8 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-06 | 179 | 199 | 8 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.55e-06 | 180 | 199 | 8 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.55e-06 | 180 | 199 | 8 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-06 | 181 | 199 | 8 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.62e-06 | 181 | 199 | 8 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-06 | 181 | 199 | 8 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.68e-06 | 182 | 199 | 8 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-06 | 183 | 199 | 8 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-06 | 183 | 199 | 8 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.75e-06 | 183 | 199 | 8 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.83e-06 | 184 | 199 | 8 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.83e-06 | 184 | 199 | 8 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 1.90e-06 | 185 | 199 | 8 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-06 | 185 | 199 | 8 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.90e-06 | 185 | 199 | 8 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.90e-06 | 185 | 199 | 8 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-06 | 185 | 199 | 8 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.98e-06 | 186 | 199 | 8 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.98e-06 | 186 | 199 | 8 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.98e-06 | 186 | 199 | 8 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.98e-06 | 186 | 199 | 8 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-06 | 187 | 199 | 8 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-06 | 187 | 199 | 8 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 2.06e-06 | 187 | 199 | 8 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-06 | 188 | 199 | 8 | 8268574584e5fb869a6cb8bbd7135cd7454a6a25 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-06 | 188 | 199 | 8 | 32f22a4d8cb98fd8b8fa0fbf28ef9266d711d081 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.15e-06 | 188 | 199 | 8 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-06 | 188 | 199 | 8 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 2.23e-06 | 189 | 199 | 8 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.23e-06 | 189 | 199 | 8 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.32e-06 | 190 | 199 | 8 | 59720dfe9de1b980807644536c919d2a02ba69dd | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.32e-06 | 190 | 199 | 8 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.32e-06 | 190 | 199 | 8 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 2.41e-06 | 191 | 199 | 8 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 2.41e-06 | 191 | 199 | 8 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-06 | 191 | 199 | 8 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.51e-06 | 192 | 199 | 8 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-06 | 193 | 199 | 8 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-06 | 193 | 199 | 8 | c8c21eee8c6c086dc2faf416669cd4a002870fbe | |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.61e-06 | 193 | 199 | 8 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-06 | 193 | 199 | 8 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.61e-06 | 193 | 199 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-06 | 193 | 199 | 8 | 5b602b1702283184bd3943c2a6f2290b7c37e407 | |
| ToppCell | (1)_Osterolineage_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.61e-06 | 193 | 199 | 8 | 035eeea9f77c4bf9cd85f07fa791b6c857be76b5 | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.71e-06 | 194 | 199 | 8 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.71e-06 | 194 | 199 | 8 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 2.71e-06 | 194 | 199 | 8 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.82e-06 | 195 | 199 | 8 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 2.92e-06 | 196 | 199 | 8 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.04e-06 | 197 | 199 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.04e-06 | 197 | 199 | 8 | a4855c5aebea4f0fed4eb035844572e82e5bac46 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.04e-06 | 197 | 199 | 8 | 61c1c29a62d4c033999b7f0183c1e9cdd6a62925 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-06 | 197 | 199 | 8 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.04e-06 | 197 | 199 | 8 | 4d63a274828ebb951db78421c2823453d862cd49 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 3.04e-06 | 197 | 199 | 8 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| Disease | neutrophil count | TET2 DENND4A AHI1 TSPOAP1 ZFP57 MAST2 PTPN14 ATXN7 FAM186A PLCB1 JCAD COL11A1 NSD1 PCDHA11 PCDHA10 CXCL1 CXCL2 POLI ANKRD11 AKAP11 LRBA TNKS2 ZMYM4 CDK6 | 7.02e-06 | 1382 | 186 | 24 | EFO_0004833 |
| Disease | vitamin D-dependent rickets (implicated_via_orthology) | 1.35e-05 | 8 | 186 | 3 | DOID:0080883 (implicated_via_orthology) | |
| Disease | alpha-2-macroglobulin measurement | 1.35e-05 | 8 | 186 | 3 | EFO_0020138 | |
| Disease | body weight | TET2 AXIN2 BPTF FASN PTPN14 RBM19 AKAP6 COL4A1 COL11A1 ANO1 ZNF521 ATP13A5 PARD3B CEP192 THSD7B CORO1A PHF3 SLIT3 LTBP1 ADAMTS14 PDZD2 CDK6 | 1.63e-05 | 1261 | 186 | 22 | EFO_0004338 |
| Disease | Liver Cirrhosis, Experimental | A2M ZFYVE16 EXTL1 TSC22D1 FAT1 MKI67 ABCG8 SERPINA7 COL4A1 FLNA VWF CXCL1 NCOR2 LOXL2 LTBP1 RASSF4 | 3.48e-05 | 774 | 186 | 16 | C0023893 |
| Disease | pulse pressure measurement | TET2 MAST2 PRKD3 FASN ATXN7 MRC2 CCDC157 COL4A1 USP36 JCAD COL11A1 ANO1 PCDHA11 PCDHA10 HEATR5A CEP164 ZFHX4 SLIT3 ANKRD11 KIAA1755 LTBP1 CDK6 | 7.12e-05 | 1392 | 186 | 22 | EFO_0005763 |
| Disease | juvenile idiopathic arthritis | 1.07e-04 | 74 | 186 | 5 | EFO_0002609 | |
| Disease | viral pneumonia (biomarker_via_orthology) | 1.18e-04 | 3 | 186 | 2 | DOID:10533 (biomarker_via_orthology) | |
| Disease | Coronavirus infectious disease (biomarker_via_orthology) | 1.18e-04 | 3 | 186 | 2 | DOID:0080599 (biomarker_via_orthology) | |
| Disease | Colorectal Carcinoma | TET2 ELOA2 OTOP2 ISLR AXIN2 FAT1 MKI67 AKAP6 SYNE1 SLC44A4 LGR5 SIGLEC7 WIF1 ZMYM4 | 1.57e-04 | 702 | 186 | 14 | C0009402 |
| Disease | Malignant neoplasm of breast | RGL1 FASN PTPN14 SEMA5B MKI67 PLCB1 AKAP6 NCOA2 FLNA COL11A1 VWF SYNE1 SMARCAL1 CXCL2 EPG5 NLRP14 LOXL2 LRBA | 1.64e-04 | 1074 | 186 | 18 | C0006142 |
| Disease | Hodgkins lymphoma | 1.74e-04 | 82 | 186 | 5 | EFO_0000183 | |
| Disease | selective IgA deficiency disease | 2.03e-04 | 46 | 186 | 4 | EFO_1001929 | |
| Disease | Autism Spectrum Disorders | 2.06e-04 | 85 | 186 | 5 | C1510586 | |
| Disease | level of growth-regulated alpha protein in blood serum | 2.35e-04 | 4 | 186 | 2 | OBA_2044955 | |
| Disease | dilated cardiomyopathy (biomarker_via_orthology) | 3.47e-04 | 22 | 186 | 3 | DOID:12930 (biomarker_via_orthology) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.52e-04 | 53 | 186 | 4 | C4707243 | |
| Disease | chemokine (C-X-C motif) ligand 1 measurement | 3.90e-04 | 5 | 186 | 2 | EFO_0008083 | |
| Disease | neutrophil count, basophil count | 5.72e-04 | 224 | 186 | 7 | EFO_0004833, EFO_0005090 | |
| Disease | aspiration pneumonia (biomarker_via_orthology) | 5.83e-04 | 6 | 186 | 2 | DOID:0050152 (biomarker_via_orthology) | |
| Disease | liposarcoma | 5.83e-04 | 6 | 186 | 2 | C0023827 | |
| Disease | protein O-linked-mannose beta-1,4-N-acetylglucosaminyltransferase 2 measurement | 5.83e-04 | 6 | 186 | 2 | EFO_0801956 | |
| Disease | esophageal cancer (biomarker_via_orthology) | 5.83e-04 | 6 | 186 | 2 | DOID:5041 (biomarker_via_orthology) | |
| Disease | kallikrein-8 measurement | 5.83e-04 | 6 | 186 | 2 | EFO_0020516 | |
| Disease | urate measurement, bone density | DAB2IP ERBIN PLCB1 USH2A FAM135A AKAP6 SYNE1 SLC44A4 LOXL2 ANKRD11 KIAA1755 PDZD2 | 5.97e-04 | 619 | 186 | 12 | EFO_0003923, EFO_0004531 |
| Disease | lung small cell carcinoma (is_implicated_in) | 7.19e-04 | 28 | 186 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | factor VIII measurement, coronary artery disease | 7.64e-04 | 113 | 186 | 5 | EFO_0001645, EFO_0004630 | |
| Disease | 1,5 anhydroglucitol measurement | 7.98e-04 | 29 | 186 | 3 | EFO_0008009 | |
| Disease | Shock, Hemorrhagic | 8.13e-04 | 7 | 186 | 2 | C0036982 | |
| Disease | sialic acid-binding Ig-like lectin 10 measurement | 8.13e-04 | 7 | 186 | 2 | EFO_0802064 | |
| Disease | retroviral-like aspartic protease 1 measurement | 8.13e-04 | 7 | 186 | 2 | EFO_0802008 | |
| Disease | colon adenoma (is_marker_for) | 8.13e-04 | 7 | 186 | 2 | DOID:0050912 (is_marker_for) | |
| Disease | MYELODYSPLASTIC SYNDROME | 8.60e-04 | 67 | 186 | 4 | C3463824 | |
| Disease | Epileptic encephalopathy | 8.83e-04 | 30 | 186 | 3 | C0543888 | |
| Disease | malate measurement | 8.83e-04 | 30 | 186 | 3 | EFO_0010508 | |
| Disease | von Willebrand factor measurement, coronary artery disease | 9.28e-04 | 118 | 186 | 5 | EFO_0001645, EFO_0004629 | |
| Disease | severe acute respiratory syndrome (biomarker_via_orthology) | 1.08e-03 | 8 | 186 | 2 | DOID:2945 (biomarker_via_orthology) | |
| Disease | mitochondrial DNA measurement | 1.18e-03 | 328 | 186 | 8 | EFO_0006312 | |
| Disease | non-small cell lung carcinoma | 1.31e-03 | 75 | 186 | 4 | EFO_0003060 | |
| Disease | sialic acid-binding Ig-like lectin 9 measurement | 1.38e-03 | 9 | 186 | 2 | EFO_0008286 | |
| Disease | CXCL1 measurement | 1.38e-03 | 9 | 186 | 2 | EFO_0010777 | |
| Disease | multimerin-2 measurement | 1.72e-03 | 10 | 186 | 2 | EFO_0801809 | |
| Disease | blood molybdenum measurement | 1.77e-03 | 38 | 186 | 3 | EFO_0007582 | |
| Disease | Epilepsy, Cryptogenic | 1.82e-03 | 82 | 186 | 4 | C0086237 | |
| Disease | Awakening Epilepsy | 1.82e-03 | 82 | 186 | 4 | C0751111 | |
| Disease | Aura | 1.82e-03 | 82 | 186 | 4 | C0236018 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.92e-03 | 139 | 186 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Colorectal Neoplasms | 1.95e-03 | 277 | 186 | 7 | C0009404 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 1.99e-03 | 84 | 186 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | triacylglycerol 56:2 measurement | 2.09e-03 | 11 | 186 | 2 | EFO_0010429 | |
| Disease | pneumonia (biomarker_via_orthology) | 2.09e-03 | 11 | 186 | 2 | DOID:552 (biomarker_via_orthology) | |
| Disease | stomach cancer (is_marker_for) | 2.11e-03 | 142 | 186 | 5 | DOID:10534 (is_marker_for) | |
| Disease | platelet-to-lymphocyte ratio | 2.23e-03 | 363 | 186 | 8 | EFO_0008446 | |
| Disease | cleft lip | 2.25e-03 | 284 | 186 | 7 | EFO_0003959 | |
| Disease | cholelithiasis | 2.36e-03 | 88 | 186 | 4 | EFO_0004799 | |
| Disease | bronchopulmonary dysplasia (biomarker_via_orthology) | 2.50e-03 | 12 | 186 | 2 | DOID:11650 (biomarker_via_orthology) | |
| Disease | prostatitis (biomarker_via_orthology) | 2.50e-03 | 12 | 186 | 2 | DOID:14654 (biomarker_via_orthology) | |
| Disease | Bronchial Hyperreactivity | 2.50e-03 | 12 | 186 | 2 | C0085129 | |
| Disease | Colonic Neoplasms | 2.83e-03 | 152 | 186 | 5 | C0009375 | |
| Disease | lean body mass | 2.90e-03 | 379 | 186 | 8 | EFO_0004995 | |
| Disease | Paroxysmal atrial fibrillation | 3.16e-03 | 156 | 186 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 3.16e-03 | 156 | 186 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.16e-03 | 156 | 186 | 5 | C2585653 | |
| Disease | bacterial pneumonia (biomarker_via_orthology) | 3.42e-03 | 14 | 186 | 2 | DOID:874 (biomarker_via_orthology) | |
| Disease | Malignant tumor of colon | 3.43e-03 | 159 | 186 | 5 | C0007102 | |
| Disease | Atrial Fibrillation | 3.52e-03 | 160 | 186 | 5 | C0004238 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.67e-03 | 49 | 186 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | myeloid cell surface antigen CD33 measurement | 3.93e-03 | 15 | 186 | 2 | EFO_0008238 | |
| Disease | glycerate measurement | 3.93e-03 | 15 | 186 | 2 | EFO_0021029 | |
| Disease | amino acid measurement | ZFYVE16 RYR3 AXIN2 RGL1 VWF SYNE1 SLIT3 LTBP1 PRKG1 LRBA TNKS2 | 3.99e-03 | 678 | 186 | 11 | EFO_0005134 |
| Disease | Alzheimer disease, polygenic risk score | MAST2 PRKD3 COL11A1 ADAMTS4 SLC6A15 ZNF45 PHF3 CNTNAP2 RNF38 LRBA | 4.21e-03 | 586 | 186 | 10 | EFO_0030082, MONDO_0004975 |
| Disease | Retinitis Pigmentosa | 4.31e-03 | 104 | 186 | 4 | C0035334 | |
| Disease | Spondyloepiphyseal Dysplasia | 4.47e-03 | 16 | 186 | 2 | C0038015 | |
| Disease | pancreatitis | 4.47e-03 | 16 | 186 | 2 | EFO_0000278 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 4.47e-03 | 16 | 186 | 2 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 4.47e-03 | 16 | 186 | 2 | C4551479 | |
| Disease | autism spectrum disorder (is_implicated_in) | 4.47e-03 | 16 | 186 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | Schwartz-Jampel Syndrome | 4.47e-03 | 16 | 186 | 2 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 4.47e-03 | 16 | 186 | 2 | C0025237 | |
| Disease | Leukemia, Myelocytic, Acute | 4.90e-03 | 173 | 186 | 5 | C0023467 | |
| Disease | esophageal carcinoma, gastric carcinoma | 5.05e-03 | 17 | 186 | 2 | EFO_0000178, EFO_0002916 | |
| Disease | immature granulocyte count | 5.05e-03 | 17 | 186 | 2 | EFO_0803542 | |
| Disease | Van Buchem disease | 5.05e-03 | 17 | 186 | 2 | C0432272 | |
| Disease | growth-regulated alpha protein measurement | 5.08e-03 | 55 | 186 | 3 | EFO_0008146 | |
| Disease | lower face morphology measurement | 5.08e-03 | 109 | 186 | 4 | EFO_0010948 | |
| Disease | Epilepsy | 5.08e-03 | 109 | 186 | 4 | C0014544 | |
| Disease | vital capacity | TET2 AHI1 NBPF12 MRC2 PLCB1 SYNE1 PCDHA11 PCDHA10 SLC6A15 NCOR2 LTBP1 PRKG1 LRBA NLRP4 PDZD2 CDK6 | 5.27e-03 | 1236 | 186 | 16 | EFO_0004312 |
| Disease | bipolar disorder, sex interaction measurement | 5.66e-03 | 18 | 186 | 2 | EFO_0008343, MONDO_0004985 | |
| Disease | serum hepcidin measurement | 5.66e-03 | 18 | 186 | 2 | EFO_0004504 | |
| Disease | coffee consumption measurement | 6.05e-03 | 182 | 186 | 5 | EFO_0006781 | |
| Disease | tonsillectomy risk measurement | 6.28e-03 | 260 | 186 | 6 | EFO_0007924 | |
| Disease | bipolar disorder (is_marker_for) | 6.30e-03 | 19 | 186 | 2 | DOID:3312 (is_marker_for) | |
| Disease | Osteochondrodysplasias | 6.30e-03 | 19 | 186 | 2 | C0029422 | |
| Disease | Cholecystitis | 6.30e-03 | 19 | 186 | 2 | HP_0001082 | |
| Disease | Dyschondroplasias | 6.30e-03 | 19 | 186 | 2 | C0013366 | |
| Disease | type 1 diabetes mellitus (biomarker_via_orthology) | 6.30e-03 | 19 | 186 | 2 | DOID:9744 (biomarker_via_orthology) | |
| Disease | hemifacial microsomia | 6.30e-03 | 19 | 186 | 2 | MONDO_0015398 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SPADTIKANQGHIPA | 71 | Q8N814 | |
| PSEHHTGPCLQDVKS | 551 | Q68DN1 | |
| PKSHNGLPVSCSENT | 621 | Q8NDL9 | |
| KKHPQTSSSGDPCQD | 1211 | Q96RT1 | |
| VPQNVGLQSSCPAKH | 191 | Q9HCE0 | |
| NVTKAGHVAQAPCPE | 441 | Q8IZF5 | |
| GTVELPKPSLCHRNS | 671 | P35626 | |
| SPFTSKTTNIQCVPH | 876 | Q4VNC0 | |
| TCLGDTPQPCHKNSQ | 11 | A0A096LP49 | |
| HPSSCNTSKAVNEPG | 216 | P0C6C1 | |
| TPKHPSQSTVCQKGT | 136 | Q6UB99 | |
| LESHRAPGPSTCQKE | 601 | Q5JQC9 | |
| APGPSTCQKENQHLD | 606 | Q5JQC9 | |
| TCPKLPHQGSFQIDE | 951 | Q8N157 | |
| NIQSVNVKSPGPHCA | 56 | P09341 | |
| NVKSPGPHCAQTEVI | 61 | P09341 | |
| CTGDSSQCPPNLHKL | 516 | O75078 | |
| GQPSSPQLVRKCVAH | 136 | Q9H221 | |
| DHLSRVLKTPGCQSP | 441 | Q9Y2T1 | |
| PKFPDSQNQLTHCSL | 986 | Q9UKA4 | |
| CKENLDSHLPPSQNT | 306 | Q00534 | |
| KAECNIHTSPSPGIQ | 96 | Q9H9E1 | |
| DKNAPTVCGHTAPVL | 71 | P31146 | |
| HKTSSQSAPACPREQ | 256 | A0A0U1RR11 | |
| TPFKINSDQATPCHL | 96 | Q96MT4 | |
| HQDKTLPPAQSSSVG | 2376 | Q12830 | |
| PCSQPSKSLLEGVTH | 701 | Q569K6 | |
| PQKAACPHQESQSHG | 416 | Q5JU67 | |
| QSPHVSEKSEAPCVR | 426 | A6NDY2 | |
| TCTQPQAGVKTPAEA | 546 | Q5H9R4 | |
| LHPINKISSTEPCTG | 1051 | Q8WXS8 | |
| QTLPQTCDEPKAHTS | 1346 | P01023 | |
| QKSGPISPGIHSCDL | 221 | Q9BUB4 | |
| PVDGNPHKTSAIVCH | 876 | Q8TBY9 | |
| PHKTSAIVCHPNGVA | 881 | Q8TBY9 | |
| HSQTIDDPQCPSGTK | 1451 | P02462 | |
| LSQNCIVDPGVSPKS | 511 | Q6P1R3 | |
| QVKSTHNCDRPPSTG | 1836 | Q7Z401 | |
| RTPEQHKSQHCSPEG | 471 | Q7Z5J4 | |
| TEKPANQKEPTTCHT | 281 | Q9Y4C8 | |
| NTLPALNQAPSSHKC | 2676 | Q96L73 | |
| AQGPSIQPVHKAESS | 106 | Q9H2L5 | |
| QLPPGHTVSQYETCK | 51 | Q9NZL6 | |
| ESIHNSPKSCPTPEV | 611 | O95153 | |
| QSPHVSEKSEAPCVR | 426 | A6NKC0 | |
| PEADSQEQVHPKTGC | 101 | O75459 | |
| VLHPGNKVTLTCVAP | 221 | P04217 | |
| SHPPISDINVNNKIC | 456 | A5PLL1 | |
| LGPNSIPAHCKVTVS | 321 | Q8TAB3 | |
| PSKCSAADLPEHQGN | 456 | Q5VWQ8 | |
| QSPHVSEKSEAPCVR | 426 | A8MXZ1 | |
| GTHCEISVNPCSSKP | 4046 | Q14517 | |
| IPSPHTEAAKDTGQN | 751 | Q9Y618 | |
| NGQVTCSLTPHVPFK | 381 | Q9Y5I1 | |
| SILHPLGTCSPQDKQ | 626 | Q8TEW8 | |
| PEKRANPCLSSSNEH | 706 | Q8IYF1 | |
| VPVKSLCHSASQSLP | 346 | Q5VYV0 | |
| SSVIFPLVKTPQCQH | 1026 | Q6P0N0 | |
| QDACSPLPKTQANHG | 2971 | Q16787 | |
| PCNTFGKPHTEVKIN | 366 | Q8TAT5 | |
| QLHPSSFPKCQEAIV | 106 | Q8NA97 | |
| QSPHVSEKSEGPCVR | 426 | Q86YD7 | |
| QAPKIVRCSTHGTPG | 1236 | Q9P2D0 | |
| QPSVTPEKASLQHNG | 481 | Q5JYT7 | |
| HKCQSVLPVPSTHIG | 41 | Q13976 | |
| GKLQTQVPNVCPHSL | 1296 | Q9Y3R5 | |
| KVTPHRCTQGDTDNP | 346 | Q9H9K5 | |
| TPKAGRSQPCVDVHG | 776 | Q9P266 | |
| PLQQKGTEQHCSSFP | 1126 | Q5HYC2 | |
| HISSCKLGPQVSLDP | 271 | Q9Y4K0 | |
| SKHSGPENNQCSLHP | 281 | O95972 | |
| TNPARTCKDLQLSHP | 1601 | P12107 | |
| QSPHVSEKSEAPCVR | 426 | A8MWA6 | |
| DNIACTSPHVLKGTP | 206 | O14498 | |
| QSPHVSEKSEAPCVR | 426 | P0C7W9 | |
| NPSHSQKEGLDPTIC | 541 | Q9P2D6 | |
| PDCPKAVHTGTAIRQ | 876 | P48058 | |
| AGPHCPTAQLIATLK | 66 | P10720 | |
| TGKLCQIPVHGASVP | 426 | Q14766 | |
| PQKCPSSTGFHIQEN | 1026 | Q9HC56 | |
| HLPTQAAICPASAKV | 1616 | O15018 | |
| PQASVCTSPGQGKDH | 536 | O94806 | |
| TKDSPVCPHFTTNGN | 976 | P50851 | |
| SGNKPTSCAVVLHSP | 1071 | Q9UBG0 | |
| TKDVRPINVSSHCPS | 166 | Q9Y337 | |
| EGPTPQTQHQLKALC | 386 | Q96MN2 | |
| LAAHCSGPQAKVLSP | 26 | Q96KJ4 | |
| NHHNTKACPDSLGSP | 961 | Q5XXA6 | |
| TPVKEQPQLTSTCHI | 761 | P46013 | |
| KSVHQICSGPVVPSL | 221 | A4D2B8 | |
| QSPHVSEKSEAPCVR | 426 | P0DV74 | |
| QCKGEPQPSSHSREL | 376 | O94886 | |
| QSPHVSEKSEAPCVR | 426 | P0DV73 | |
| SPCDSNQPHKNINIT | 216 | Q3BBV0 | |
| KSVPAHGTTLNAQPA | 616 | O15265 | |
| QSPHVSEKSEAPCVR | 426 | P0DV76 | |
| SSSHPQPCQILKRIG | 31 | Q8TCU5 | |
| NGQVTCSLTPHVPFK | 381 | Q9Y5I2 | |
| STHPKEPCQDLTFTN | 436 | Q7RTS6 | |
| QSPHVSEKSEAPCVR | 426 | A6NJQ4 | |
| HKSSQPITCKGNPVE | 431 | Q9Y236 | |
| HDNSKPCISLNGPLS | 371 | O75173 | |
| PSHPKATQTQIDAVC | 336 | Q86XA9 | |
| GHASPDTGPCVNQKQ | 436 | Q0VDD7 | |
| NIQSVKVKSPGPHCA | 56 | P19875 | |
| PPEVISCHQKSPAST | 1596 | Q4AC94 | |
| HKTSSQSAPACPREQ | 256 | P0DPI3 | |
| DSLTKATCAPQHGAP | 2536 | P21333 | |
| SCLNRDSVPDNHPTK | 6 | O43559 | |
| PACHKTVIPNNSFVS | 451 | Q6P158 | |
| PEADSQEQVHPKTGC | 71 | A6NGK3 | |
| HKTSSQSAPACPREQ | 256 | A0A0U1RRI6 | |
| TDKCTQLALPPSGIH | 391 | P09172 | |
| IISGCRHPKDNSPVV | 11 | P01880 | |
| TKTPECPSHTQPLGV | 156 | P01880 | |
| KPIGATHNCNVADPA | 171 | Q86UU0 | |
| EGCVKPPTVIGQFHT | 11 | A6NN92 | |
| IPTCHDKPGTTQIVQ | 236 | Q8IWF6 | |
| KAQLESCLPSPTHEA | 161 | Q8WWX0 | |
| PPEGNLHCSESASKL | 421 | Q6IQ26 | |
| SCSSQEKLHQLPFQP | 251 | Q6P0Q8 | |
| AALETHCSNISNVPP | 251 | Q9NWL6 | |
| LTDPVKQGAECPHQN | 386 | Q8TEP8 | |
| VTPQHGCVAPESKLQ | 2176 | Q8TEP8 | |
| VKPISLADHCTQPGQ | 136 | O60259 | |
| SEHCIPKTLQSKPQS | 646 | A4D0S4 | |
| ASNISSPGCEKVPIN | 391 | Q53GD3 | |
| KVPINTSCNPTAHLV | 401 | Q53GD3 | |
| GLCEPTPQDHIKVTQ | 351 | P22681 | |
| SQNCHPANLEVTSPK | 31 | Q8IYX8 | |
| TSQKCDEPLVSGLPH | 31 | Q9UHC6 | |
| CTAAHPELKTPLTAN | 191 | P01877 | |
| QSPHVSEKSEAPCVR | 426 | A6NIJ5 | |
| GQPLTKCIHLTPQQA | 1066 | A6NE01 | |
| PGVVPACHNSKDTVT | 636 | P49327 | |
| KENVGPSCHLIIPTF | 1131 | Q9C0D2 | |
| QSPHVSEKSEAPCVR | 426 | A8MXJ8 | |
| QCPIPSHVIQKLGTG | 386 | Q9UNA4 | |
| QSPHVSEKSEAPCVR | 426 | P0C7X0 | |
| SECDPTPSHRGQLNK | 891 | Q9BXW9 | |
| EDLKALHSVQCSPSP | 531 | O75473 | |
| ECPTVAPAHSLTKSQ | 576 | Q9UPQ0 | |
| NRKHPSSPECLVSAQ | 71 | Q14980 | |
| PARTSPLVSGHCKNI | 246 | Q2NL67 | |
| GVKPSTVHIACTPQA | 51 | Q96FA3 | |
| KDNGEPPCSATATLH | 646 | Q9UN66 | |
| PVPHNIKISNITCDS | 51 | Q96FC7 | |
| SSCITPDKNDLHPNA | 106 | O75445 | |
| QPLEGPKHSCASTQL | 21 | Q9BSD3 | |
| QCPLVKNASHTFVEP | 181 | Q9H2J7 | |
| SASLPGHPNKVICER | 11 | Q9H0F5 | |
| GSITNQLLKECHPPV | 7191 | Q8NF91 | |
| VPNQSCRPHGSKLTH | 491 | O14513 | |
| GPCDSIQPHKNIKIT | 181 | Q3BBV2 | |
| GPCDSIQPHKNIKIT | 216 | Q86T75 | |
| GPCDSIQPHKNIKIT | 216 | Q5TAG4 | |
| PSLIKNTGVACPASQ | 511 | Q5VVP1 | |
| QSPHVSEKSEAPCVR | 426 | A8MX19 | |
| QSPHVSEKSEAPCVR | 426 | A6NNJ1 | |
| QSPHVSEKSEAPCVR | 426 | P0C7W8 | |
| TKLQGSVQPSCPEHS | 596 | O75343 | |
| GVASLPPAKCQHQES | 91 | Q5JXC2 | |
| NNVVPSKPGASAISH | 521 | Q15678 | |
| NFPRESCKPVSHGVI | 56 | Q9NZC9 | |
| KTLQCSCSFHGIPTP | 21 | Q8N7X8 | |
| PQPQHHGTSLTCQVT | 206 | Q9Y286 | |
| LTPKPQDHGTSLTCQ | 211 | Q9NYZ4 | |
| APGHVKSVTQNPASE | 641 | Q15714 | |
| SASGPKQDHVQCPEA | 2826 | Q9P2P6 | |
| ITPKAHLPLGQSNSC | 921 | Q86SQ0 | |
| KQEPCAQHNGSEPAS | 316 | Q8N6T7 | |
| SQHNCSKDGPTSQPR | 111 | Q96B86 | |
| QSPHVSEKSEAPCVR | 426 | P0C7V4 | |
| PPLKLIQAVAGSQHC | 431 | Q92935 | |
| AALHPSPKTLTCEEN | 2291 | Q13023 | |
| SPPAACEKGKEQHSQ | 531 | Q9UPV0 | |
| PDHNSISEIPFKCNG | 231 | Q8IXR9 | |
| ESSCHPGEQKETNDP | 601 | Q15596 | |
| LTTPTHRFQCKGPVD | 896 | O75094 | |
| SQCPPIKFISADVHG | 176 | A0AVT1 | |
| SNVLHPNGECPVKSE | 451 | Q86UP3 | |
| IFSHNSPGNKCPITE | 611 | O75762 | |
| SKPLCSVQGRPETGH | 141 | Q86XK7 | |
| LCQDARSNSHPVKPS | 281 | Q9NU63 | |
| KEQDRVHSPCPTSGS | 101 | Q96LT9 | |
| KVPLDSSPATCHNNI | 1036 | P04275 | |
| PSHCGSLQHSKPVDV | 516 | O95428 | |
| SLQHSKPVDVEPCNT | 521 | O95428 | |
| SHPGNKSPVSQLDCL | 516 | Q04727 | |
| PPCLKVTHKTFGTQN | 1266 | Q15413 | |
| CVNLSKSASPGINVP | 1096 | Q96K83 | |
| ASPEGKVTACHSSQP | 21 | P05543 | |
| NKVIHCTVPPGVDSF | 101 | Q9H0E2 | |
| SKHKCNNPGEIDVPS | 236 | Q92576 | |
| GPALPCHKISVSNID | 41 | Q6UXR4 | |
| TVPHKASVVQVGFPC | 126 | Q9Y5W5 | |
| TTKDHGPVFGPCSQL | 26 | P12271 | |
| PSSEQQLCALSKHPT | 91 | Q9P283 | |
| LVHGCFNASIPKPEQ | 146 | Q3B726 | |
| SSNTPNKGLPLHCDQ | 801 | Q6AHZ1 | |
| SQALHSQPAPGSVKA | 876 | Q9NQ66 | |
| IKAGPHCPTAQLIAT | 61 | P02776 | |
| LNCHNKSAIDLAPTP | 306 | Q9H2K2 | |
| DPDRPVHCSKNTLNG | 256 | Q9HB20 | |
| TVFPGNKTHNAVCVP | 141 | Q9Y5U5 | |
| PCLSSQKVHPSETCG | 76 | Q8NEK5 | |
| HNSTFLECLPKSPQA | 596 | Q9NS98 | |
| SHLSNCGESNRPPKE | 76 | Q9C0I4 | |
| KATQACGHQLPASQP | 326 | Q53SZ7 | |
| KVTCKHPVTGQPSQD | 81 | Q9HAU0 | |
| ICPSPAENNIQGTTK | 331 | Q6N021 | |
| SHLCQLAAKPAPSTD | 321 | Q04725 | |
| SHCQAPLIVHTGEKP | 261 | Q02386 | |
| QEVPHISQPCQKSSQ | 1301 | Q6PFW1 | |
| PHTQNKECQTEDTPS | 961 | Q5VZL5 | |
| QETNCSTAGHSKTPP | 641 | Q9P275 | |
| LKSNHSDECTTVQPP | 821 | Q7Z3T8 | |
| HSKPTCRLVPSQGDS | 131 | Q8NC26 | |
| CHSVKSLQRQPGASP | 116 | Q6AW86 | |
| VAKTGPESNQCLPHH | 1486 | Q9BYP7 | |
| QSPHVSEKSEAPCVR | 426 | P0DV75 | |
| RTVCLIPKSAHGTNP | 641 | P23378 | |
| VCPPGGIHQVTVNKS | 106 | Q7RTS7 | |
| VGVSNPHLIIKPDCN | 1066 | Q86W24 | |
| PITAHLCTAKSPQQV | 186 | Q9UHQ1 |